Brief: Cipher Pharmaceuticals Inc - QTRLY Total Revenue Decreased To $5.6 Million From $7.0 Million.

Cipher Pharmaceuticals

09/08/2019 12:29

Cipher Pharmaceuticals Inc  CPH.TO :
    * CIPHER PHARMACEUTICALS REPORTS SECOND QUARTER 2019
FINANCIAL
RESULTS
    * CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE DECREASED
TO
$5.6 MILLION FROM $7.0 MILLION.
    * CIPHER PHARMACEUTICALS INC - QTRLY NET INCOME FROM
CONTINUING
OPERATIONS $0.05 PER BASIC AND DILUTED SHARE
    * CIPHER PHARMACEUTICALS - INTENDS TO SIGNIFICANTLY INCREASE
COLLABORATION WITH TECHNOLOGY PARTNER GALEPHAR PHARMACEUTICAL
RESEARCH
    * CIPHER PHARMACEUTICALS - COMMERCIAL INVESTMENTS WILL BE
ASSUMED
BY PARTNERS AND CIPHER INTENDS TO COLLECT UPFRONT PAYMENTS AND
ROYALTY STREAMS.

Source text for Eikon:  ID:nCNW7JsvNa 
Further company coverage:  CPH.TO